nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—UGT1A9—Irinotecan—stomach cancer	0.509	1	CbGbCtD
Entacapone—UGT1A9—Nicotine Metabolism—CYP2A6—stomach cancer	0.00438	0.0859	CbGpPWpGaD
Entacapone—UGT1A9—digestive system—stomach cancer	0.0031	0.144	CbGeAlD
Entacapone—UGT1A9—endocrine gland—stomach cancer	0.00256	0.119	CbGeAlD
Entacapone—COMT—hematopoietic system—stomach cancer	0.00244	0.114	CbGeAlD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.00232	0.0456	CbGpPWpGaD
Entacapone—UGT1A9—liver—stomach cancer	0.00231	0.108	CbGeAlD
Entacapone—COMT—smooth muscle tissue—stomach cancer	0.00215	0.1	CbGeAlD
Entacapone—COMT—pancreas—stomach cancer	0.00199	0.0927	CbGeAlD
Entacapone—COMT—Estrogen metabolism—GSTM1—stomach cancer	0.00196	0.0384	CbGpPWpGaD
Entacapone—COMT—digestive system—stomach cancer	0.0017	0.0792	CbGeAlD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SERPINB2—stomach cancer	0.00159	0.0312	CbGpPWpGaD
Entacapone—COMT—bone marrow—stomach cancer	0.00157	0.073	CbGeAlD
Entacapone—COMT—endocrine gland—stomach cancer	0.0014	0.0654	CbGeAlD
Entacapone—COMT—liver—stomach cancer	0.00127	0.059	CbGeAlD
Entacapone—UGT1A9—Estrogen metabolism—GSTM1—stomach cancer	0.00117	0.023	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.00115	0.0225	CbGpPWpGaD
Entacapone—UGT1A9—Irinotecan Pathway—APC—stomach cancer	0.00106	0.0209	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—AHR—stomach cancer	0.00102	0.0201	CbGpPWpGaD
Entacapone—COMT—lymph node—stomach cancer	0.000971	0.0452	CbGeAlD
Entacapone—COMT—Phase II conjugation—GSTT1—stomach cancer	0.000862	0.0169	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—PLIN2—stomach cancer	0.000813	0.016	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—BLVRB—stomach cancer	0.000811	0.0159	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—stomach cancer	0.000796	0.0156	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—APOA1—stomach cancer	0.00071	0.0139	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—CDK4—stomach cancer	0.000688	0.0135	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC1A2—stomach cancer	0.000678	0.0133	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—FADS1—stomach cancer	0.000616	0.0121	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—stomach cancer	0.000603	0.0118	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTP1—stomach cancer	0.000598	0.0117	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—SREBF2—stomach cancer	0.000577	0.0113	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—RORA—stomach cancer	0.00057	0.0112	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—SREBF2—stomach cancer	0.000565	0.0111	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RORA—stomach cancer	0.000558	0.011	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTM1—stomach cancer	0.000549	0.0108	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—stomach cancer	0.000548	0.0108	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC1A2—stomach cancer	0.00052	0.0102	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTT1—stomach cancer	0.000517	0.0101	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTT1—stomach cancer	0.000505	0.0099	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP2A6—stomach cancer	0.000499	0.00979	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—AKR1C3—stomach cancer	0.000478	0.00939	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—CCND1—stomach cancer	0.000445	0.00872	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ECHS1—stomach cancer	0.000442	0.00867	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—stomach cancer	0.000416	0.00816	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—HSPA8—stomach cancer	0.000405	0.00795	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—SREBF2—stomach cancer	0.000389	0.00764	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—RORA—stomach cancer	0.000385	0.00755	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFA—stomach cancer	0.000378	0.00741	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SERPINA1—stomach cancer	0.000372	0.00731	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTP1—stomach cancer	0.000358	0.00703	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—MYC—stomach cancer	0.000357	0.007	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTP1—stomach cancer	0.00035	0.00686	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTP1—stomach cancer	0.000345	0.00677	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—CYP2A6—stomach cancer	0.000341	0.00668	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTM1—stomach cancer	0.000329	0.00646	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTM1—stomach cancer	0.000321	0.00631	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTM1—stomach cancer	0.000317	0.00622	CbGpPWpGaD
Entacapone—COMT—Neuronal System—HSPA8—stomach cancer	0.00031	0.00609	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTT1—stomach cancer	0.000302	0.00593	CbGpPWpGaD
Entacapone—COMT—Metabolism—ACAD8—stomach cancer	0.000301	0.0059	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP2A6—stomach cancer	0.000299	0.00586	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	0.000295	0.00579	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	0.00029	0.00569	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—AKR1C3—stomach cancer	0.000287	0.00562	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	0.000281	0.00552	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HBEGF—stomach cancer	0.000269	0.00528	CbGpPWpGaD
Entacapone—COMT—Metabolism—GMPR2—stomach cancer	0.000268	0.00526	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000261	0.00511	CbGpPWpGaD
Entacapone—Agranulocytosis—Doxorubicin—stomach cancer	0.000253	0.000603	CcSEcCtD
Entacapone—Rash—Irinotecan—stomach cancer	0.000252	0.000603	CcSEcCtD
Entacapone—Dermatitis—Irinotecan—stomach cancer	0.000252	0.000602	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000252	0.000602	CcSEcCtD
Entacapone—Headache—Irinotecan—stomach cancer	0.000251	0.000599	CcSEcCtD
Entacapone—Hypotension—Capecitabine—stomach cancer	0.00025	0.000598	CcSEcCtD
Entacapone—Insomnia—Docetaxel—stomach cancer	0.00025	0.000597	CcSEcCtD
Entacapone—Paraesthesia—Docetaxel—stomach cancer	0.000248	0.000593	CcSEcCtD
Entacapone—Erythema multiforme—Epirubicin—stomach cancer	0.000248	0.000593	CcSEcCtD
Entacapone—Alopecia—Methotrexate—stomach cancer	0.000248	0.000592	CcSEcCtD
Entacapone—Bradycardia—Doxorubicin—stomach cancer	0.000247	0.000591	CcSEcCtD
Entacapone—Dyspnoea—Docetaxel—stomach cancer	0.000247	0.000589	CcSEcCtD
Entacapone—Somnolence—Docetaxel—stomach cancer	0.000246	0.000587	CcSEcCtD
Entacapone—Mental disorder—Methotrexate—stomach cancer	0.000246	0.000587	CcSEcCtD
Entacapone—Eye disorder—Epirubicin—stomach cancer	0.000245	0.000586	CcSEcCtD
Entacapone—COMT—Metabolism—SUCLG1—stomach cancer	0.000245	0.00481	CbGpPWpGaD
Entacapone—COMT—Metabolism—IDH3B—stomach cancer	0.000245	0.00481	CbGpPWpGaD
Entacapone—Malnutrition—Methotrexate—stomach cancer	0.000244	0.000583	CcSEcCtD
Entacapone—Haemoglobin—Doxorubicin—stomach cancer	0.000244	0.000583	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000244	0.000583	CcSEcCtD
Entacapone—Cardiac disorder—Epirubicin—stomach cancer	0.000244	0.000582	CcSEcCtD
Entacapone—Flushing—Epirubicin—stomach cancer	0.000244	0.000582	CcSEcCtD
Entacapone—Vomiting—Fluorouracil—stomach cancer	0.000244	0.000582	CcSEcCtD
Entacapone—Dyspepsia—Docetaxel—stomach cancer	0.000243	0.000582	CcSEcCtD
Entacapone—Haemorrhage—Doxorubicin—stomach cancer	0.000243	0.00058	CcSEcCtD
Entacapone—Hepatitis—Doxorubicin—stomach cancer	0.000243	0.00058	CcSEcCtD
Entacapone—Insomnia—Capecitabine—stomach cancer	0.000242	0.000578	CcSEcCtD
Entacapone—Hypoaesthesia—Doxorubicin—stomach cancer	0.000242	0.000577	CcSEcCtD
Entacapone—Rash—Fluorouracil—stomach cancer	0.000242	0.000577	CcSEcCtD
Entacapone—Dermatitis—Fluorouracil—stomach cancer	0.000241	0.000577	CcSEcCtD
Entacapone—Pharyngitis—Doxorubicin—stomach cancer	0.000241	0.000576	CcSEcCtD
Entacapone—Paraesthesia—Capecitabine—stomach cancer	0.00024	0.000574	CcSEcCtD
Entacapone—Decreased appetite—Docetaxel—stomach cancer	0.00024	0.000574	CcSEcCtD
Entacapone—Headache—Fluorouracil—stomach cancer	0.00024	0.000573	CcSEcCtD
Entacapone—Urinary tract disorder—Doxorubicin—stomach cancer	0.00024	0.000573	CcSEcCtD
Entacapone—Dysgeusia—Methotrexate—stomach cancer	0.000239	0.000571	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—GSTP1—stomach cancer	0.000239	0.00469	CbGpPWpGaD
Entacapone—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000239	0.00057	CcSEcCtD
Entacapone—Dyspnoea—Capecitabine—stomach cancer	0.000239	0.00057	CcSEcCtD
Entacapone—Fatigue—Docetaxel—stomach cancer	0.000238	0.00057	CcSEcCtD
Entacapone—Urethral disorder—Doxorubicin—stomach cancer	0.000238	0.000569	CcSEcCtD
Entacapone—Nausea—Irinotecan—stomach cancer	0.000238	0.000568	CcSEcCtD
Entacapone—Pain—Docetaxel—stomach cancer	0.000237	0.000565	CcSEcCtD
Entacapone—Constipation—Docetaxel—stomach cancer	0.000237	0.000565	CcSEcCtD
Entacapone—Back pain—Methotrexate—stomach cancer	0.000236	0.000564	CcSEcCtD
Entacapone—Dyspepsia—Capecitabine—stomach cancer	0.000236	0.000563	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—HMOX1—stomach cancer	0.000236	0.00462	CbGpPWpGaD
Entacapone—Visual impairment—Doxorubicin—stomach cancer	0.000234	0.000559	CcSEcCtD
Entacapone—Decreased appetite—Capecitabine—stomach cancer	0.000233	0.000556	CcSEcCtD
Entacapone—Alopecia—Epirubicin—stomach cancer	0.000232	0.000554	CcSEcCtD
Entacapone—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000231	0.000552	CcSEcCtD
Entacapone—Fatigue—Capecitabine—stomach cancer	0.000231	0.000551	CcSEcCtD
Entacapone—Vision blurred—Methotrexate—stomach cancer	0.00023	0.00055	CcSEcCtD
Entacapone—Mental disorder—Epirubicin—stomach cancer	0.00023	0.000549	CcSEcCtD
Entacapone—Erythema multiforme—Doxorubicin—stomach cancer	0.00023	0.000549	CcSEcCtD
Entacapone—Pain—Capecitabine—stomach cancer	0.000229	0.000547	CcSEcCtD
Entacapone—Constipation—Capecitabine—stomach cancer	0.000229	0.000547	CcSEcCtD
Entacapone—Malnutrition—Epirubicin—stomach cancer	0.000229	0.000546	CcSEcCtD
Entacapone—Feeling abnormal—Docetaxel—stomach cancer	0.000228	0.000544	CcSEcCtD
Entacapone—COMT—Metabolism—NDUFV1—stomach cancer	0.000228	0.00447	CbGpPWpGaD
Entacapone—COMT—Metabolism—NDUFS1—stomach cancer	0.000228	0.00447	CbGpPWpGaD
Entacapone—Nausea—Fluorouracil—stomach cancer	0.000228	0.000544	CcSEcCtD
Entacapone—Eye disorder—Doxorubicin—stomach cancer	0.000227	0.000542	CcSEcCtD
Entacapone—Ill-defined disorder—Methotrexate—stomach cancer	0.000227	0.000541	CcSEcCtD
Entacapone—Gastrointestinal pain—Docetaxel—stomach cancer	0.000226	0.00054	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—stomach cancer	0.000226	0.000539	CcSEcCtD
Entacapone—Flushing—Doxorubicin—stomach cancer	0.000226	0.000539	CcSEcCtD
Entacapone—Flatulence—Epirubicin—stomach cancer	0.000225	0.000538	CcSEcCtD
Entacapone—Tension—Epirubicin—stomach cancer	0.000224	0.000536	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—APOA1—stomach cancer	0.000224	0.00439	CbGpPWpGaD
Entacapone—Dysgeusia—Epirubicin—stomach cancer	0.000224	0.000535	CcSEcCtD
Entacapone—Nervousness—Epirubicin—stomach cancer	0.000222	0.00053	CcSEcCtD
Entacapone—Back pain—Epirubicin—stomach cancer	0.000221	0.000528	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000221	0.00434	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	0.000221	0.00434	CbGpPWpGaD
Entacapone—Feeling abnormal—Capecitabine—stomach cancer	0.000221	0.000527	CcSEcCtD
Entacapone—Malaise—Methotrexate—stomach cancer	0.00022	0.000526	CcSEcCtD
Entacapone—Muscle spasms—Epirubicin—stomach cancer	0.00022	0.000525	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—GSTM1—stomach cancer	0.000219	0.00431	CbGpPWpGaD
Entacapone—Vertigo—Methotrexate—stomach cancer	0.000219	0.000524	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—stomach cancer	0.000219	0.0043	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Capecitabine—stomach cancer	0.000219	0.000523	CcSEcCtD
Entacapone—Body temperature increased—Docetaxel—stomach cancer	0.000219	0.000522	CcSEcCtD
Entacapone—Abdominal pain—Docetaxel—stomach cancer	0.000219	0.000522	CcSEcCtD
Entacapone—Leukopenia—Methotrexate—stomach cancer	0.000219	0.000522	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000218	0.00429	CbGpPWpGaD
Entacapone—Vision blurred—Epirubicin—stomach cancer	0.000215	0.000515	CcSEcCtD
Entacapone—Alopecia—Doxorubicin—stomach cancer	0.000215	0.000513	CcSEcCtD
Entacapone—Cough—Methotrexate—stomach cancer	0.000213	0.000509	CcSEcCtD
Entacapone—Mental disorder—Doxorubicin—stomach cancer	0.000213	0.000508	CcSEcCtD
Entacapone—Urticaria—Capecitabine—stomach cancer	0.000213	0.000508	CcSEcCtD
Entacapone—Ill-defined disorder—Epirubicin—stomach cancer	0.000212	0.000507	CcSEcCtD
Entacapone—Body temperature increased—Capecitabine—stomach cancer	0.000212	0.000506	CcSEcCtD
Entacapone—Abdominal pain—Capecitabine—stomach cancer	0.000212	0.000506	CcSEcCtD
Entacapone—Convulsion—Methotrexate—stomach cancer	0.000212	0.000505	CcSEcCtD
Entacapone—Malnutrition—Doxorubicin—stomach cancer	0.000212	0.000505	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	0.00021	0.00413	CbGpPWpGaD
Entacapone—Agitation—Epirubicin—stomach cancer	0.00021	0.000502	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—GSTP1—stomach cancer	0.000209	0.00411	CbGpPWpGaD
Entacapone—Flatulence—Doxorubicin—stomach cancer	0.000208	0.000498	CcSEcCtD
Entacapone—Chest pain—Methotrexate—stomach cancer	0.000208	0.000497	CcSEcCtD
Entacapone—Myalgia—Methotrexate—stomach cancer	0.000208	0.000497	CcSEcCtD
Entacapone—Tension—Doxorubicin—stomach cancer	0.000208	0.000496	CcSEcCtD
Entacapone—Dysgeusia—Doxorubicin—stomach cancer	0.000207	0.000495	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—GSTP1—stomach cancer	0.000207	0.00405	CbGpPWpGaD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000207	0.000493	CcSEcCtD
Entacapone—Malaise—Epirubicin—stomach cancer	0.000206	0.000492	CcSEcCtD
Entacapone—Discomfort—Methotrexate—stomach cancer	0.000205	0.000491	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—stomach cancer	0.000205	0.000491	CcSEcCtD
Entacapone—Vertigo—Epirubicin—stomach cancer	0.000205	0.000491	CcSEcCtD
Entacapone—Syncope—Epirubicin—stomach cancer	0.000205	0.00049	CcSEcCtD
Entacapone—Leukopenia—Epirubicin—stomach cancer	0.000205	0.000489	CcSEcCtD
Entacapone—Back pain—Doxorubicin—stomach cancer	0.000205	0.000489	CcSEcCtD
Entacapone—Hypersensitivity—Docetaxel—stomach cancer	0.000204	0.000487	CcSEcCtD
Entacapone—Muscle spasms—Doxorubicin—stomach cancer	0.000203	0.000486	CcSEcCtD
Entacapone—COMT—Metabolism—BLVRB—stomach cancer	0.000203	0.00398	CbGpPWpGaD
Entacapone—COMT—Metabolism—PGLS—stomach cancer	0.000203	0.00398	CbGpPWpGaD
Entacapone—Palpitations—Epirubicin—stomach cancer	0.000202	0.000482	CcSEcCtD
Entacapone—Confusional state—Methotrexate—stomach cancer	0.000201	0.00048	CcSEcCtD
Entacapone—Loss of consciousness—Epirubicin—stomach cancer	0.000201	0.00048	CcSEcCtD
Entacapone—Cough—Epirubicin—stomach cancer	0.000199	0.000476	CcSEcCtD
Entacapone—Vision blurred—Doxorubicin—stomach cancer	0.000199	0.000476	CcSEcCtD
Entacapone—Asthenia—Docetaxel—stomach cancer	0.000198	0.000474	CcSEcCtD
Entacapone—Convulsion—Epirubicin—stomach cancer	0.000198	0.000473	CcSEcCtD
Entacapone—Hypertension—Epirubicin—stomach cancer	0.000197	0.000471	CcSEcCtD
Entacapone—Hypersensitivity—Capecitabine—stomach cancer	0.000197	0.000471	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—PPARG—stomach cancer	0.000197	0.00387	CbGpPWpGaD
Entacapone—Ill-defined disorder—Doxorubicin—stomach cancer	0.000196	0.000469	CcSEcCtD
Entacapone—Pruritus—Docetaxel—stomach cancer	0.000196	0.000467	CcSEcCtD
Entacapone—Nervous system disorder—Methotrexate—stomach cancer	0.000196	0.000467	CcSEcCtD
Entacapone—Thrombocytopenia—Methotrexate—stomach cancer	0.000195	0.000466	CcSEcCtD
Entacapone—Myalgia—Epirubicin—stomach cancer	0.000195	0.000465	CcSEcCtD
Entacapone—Chest pain—Epirubicin—stomach cancer	0.000195	0.000465	CcSEcCtD
Entacapone—Agitation—Doxorubicin—stomach cancer	0.000194	0.000464	CcSEcCtD
Entacapone—Anxiety—Epirubicin—stomach cancer	0.000194	0.000463	CcSEcCtD
Entacapone—COMT—Metabolism—PPAP2A—stomach cancer	0.000194	0.0038	CbGpPWpGaD
Entacapone—Skin disorder—Methotrexate—stomach cancer	0.000194	0.000462	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000193	0.000462	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—stomach cancer	0.000193	0.00379	CbGpPWpGaD
Entacapone—Hyperhidrosis—Methotrexate—stomach cancer	0.000193	0.00046	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—GSTM1—stomach cancer	0.000193	0.00378	CbGpPWpGaD
Entacapone—Discomfort—Epirubicin—stomach cancer	0.000192	0.000459	CcSEcCtD
Entacapone—Asthenia—Capecitabine—stomach cancer	0.000192	0.000459	CcSEcCtD
Entacapone—Malaise—Doxorubicin—stomach cancer	0.000191	0.000456	CcSEcCtD
Entacapone—Dry mouth—Epirubicin—stomach cancer	0.00019	0.000455	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—stomach cancer	0.00019	0.000454	CcSEcCtD
Entacapone—Anorexia—Methotrexate—stomach cancer	0.00019	0.000454	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM1—stomach cancer	0.00019	0.00373	CbGpPWpGaD
Entacapone—Syncope—Doxorubicin—stomach cancer	0.00019	0.000453	CcSEcCtD
Entacapone—Pruritus—Capecitabine—stomach cancer	0.000189	0.000453	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—stomach cancer	0.000189	0.000452	CcSEcCtD
Entacapone—Diarrhoea—Docetaxel—stomach cancer	0.000189	0.000452	CcSEcCtD
Entacapone—Confusional state—Epirubicin—stomach cancer	0.000188	0.000449	CcSEcCtD
Entacapone—Palpitations—Doxorubicin—stomach cancer	0.000187	0.000446	CcSEcCtD
Entacapone—Oedema—Epirubicin—stomach cancer	0.000187	0.000446	CcSEcCtD
Entacapone—Hypotension—Methotrexate—stomach cancer	0.000186	0.000445	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—stomach cancer	0.000186	0.000444	CcSEcCtD
Entacapone—Cough—Doxorubicin—stomach cancer	0.000185	0.000441	CcSEcCtD
Entacapone—Shock—Epirubicin—stomach cancer	0.000184	0.000438	CcSEcCtD
Entacapone—Convulsion—Doxorubicin—stomach cancer	0.000183	0.000438	CcSEcCtD
Entacapone—Diarrhoea—Capecitabine—stomach cancer	0.000183	0.000438	CcSEcCtD
Entacapone—Nervous system disorder—Epirubicin—stomach cancer	0.000183	0.000437	CcSEcCtD
Entacapone—Dizziness—Docetaxel—stomach cancer	0.000183	0.000437	CcSEcCtD
Entacapone—Thrombocytopenia—Epirubicin—stomach cancer	0.000183	0.000436	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—stomach cancer	0.000183	0.000436	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000182	0.000434	CcSEcCtD
Entacapone—Skin disorder—Epirubicin—stomach cancer	0.000181	0.000433	CcSEcCtD
Entacapone—Hyperhidrosis—Epirubicin—stomach cancer	0.00018	0.000431	CcSEcCtD
Entacapone—Insomnia—Methotrexate—stomach cancer	0.00018	0.000431	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ACAD8—stomach cancer	0.00018	0.00353	CbGpPWpGaD
Entacapone—Chest pain—Doxorubicin—stomach cancer	0.00018	0.00043	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—stomach cancer	0.00018	0.00043	CcSEcCtD
Entacapone—Anxiety—Doxorubicin—stomach cancer	0.000179	0.000429	CcSEcCtD
Entacapone—Paraesthesia—Methotrexate—stomach cancer	0.000179	0.000428	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000179	0.000427	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—stomach cancer	0.000178	0.000425	CcSEcCtD
Entacapone—Anorexia—Epirubicin—stomach cancer	0.000178	0.000425	CcSEcCtD
Entacapone—Dyspnoea—Methotrexate—stomach cancer	0.000178	0.000424	CcSEcCtD
Entacapone—Somnolence—Methotrexate—stomach cancer	0.000177	0.000423	CcSEcCtD
Entacapone—Dizziness—Capecitabine—stomach cancer	0.000177	0.000423	CcSEcCtD
Entacapone—Dry mouth—Doxorubicin—stomach cancer	0.000176	0.000421	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000176	0.00345	CbGpPWpGaD
Entacapone—Vomiting—Docetaxel—stomach cancer	0.000176	0.00042	CcSEcCtD
Entacapone—Dyspepsia—Methotrexate—stomach cancer	0.000175	0.000419	CcSEcCtD
Entacapone—Rash—Docetaxel—stomach cancer	0.000174	0.000417	CcSEcCtD
Entacapone—Hypotension—Epirubicin—stomach cancer	0.000174	0.000416	CcSEcCtD
Entacapone—Dermatitis—Docetaxel—stomach cancer	0.000174	0.000416	CcSEcCtD
Entacapone—Confusional state—Doxorubicin—stomach cancer	0.000174	0.000416	CcSEcCtD
Entacapone—Decreased appetite—Methotrexate—stomach cancer	0.000173	0.000414	CcSEcCtD
Entacapone—Headache—Docetaxel—stomach cancer	0.000173	0.000414	CcSEcCtD
Entacapone—COMT—Metabolism—FBP1—stomach cancer	0.000173	0.00339	CbGpPWpGaD
Entacapone—COMT—Metabolism—NDUFA2—stomach cancer	0.000173	0.00339	CbGpPWpGaD
Entacapone—COMT—Metabolism—CKB—stomach cancer	0.000173	0.00339	CbGpPWpGaD
Entacapone—COMT—Metabolism—CA1—stomach cancer	0.000173	0.00339	CbGpPWpGaD
Entacapone—Oedema—Doxorubicin—stomach cancer	0.000173	0.000412	CcSEcCtD
Entacapone—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000172	0.000411	CcSEcCtD
Entacapone—Fatigue—Methotrexate—stomach cancer	0.000172	0.00041	CcSEcCtD
Entacapone—Pain—Methotrexate—stomach cancer	0.00017	0.000407	CcSEcCtD
Entacapone—Vomiting—Capecitabine—stomach cancer	0.00017	0.000407	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00017	0.000406	CcSEcCtD
Entacapone—Shock—Doxorubicin—stomach cancer	0.00017	0.000406	CcSEcCtD
Entacapone—COMT—Neuronal System—PRKCB—stomach cancer	0.000169	0.00332	CbGpPWpGaD
Entacapone—Nervous system disorder—Doxorubicin—stomach cancer	0.000169	0.000404	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—stomach cancer	0.000169	0.000404	CcSEcCtD
Entacapone—Rash—Capecitabine—stomach cancer	0.000169	0.000403	CcSEcCtD
Entacapone—Insomnia—Epirubicin—stomach cancer	0.000169	0.000403	CcSEcCtD
Entacapone—Dermatitis—Capecitabine—stomach cancer	0.000169	0.000403	CcSEcCtD
Entacapone—Headache—Capecitabine—stomach cancer	0.000168	0.000401	CcSEcCtD
Entacapone—Skin disorder—Doxorubicin—stomach cancer	0.000168	0.0004	CcSEcCtD
Entacapone—Paraesthesia—Epirubicin—stomach cancer	0.000168	0.0004	CcSEcCtD
Entacapone—Hyperhidrosis—Doxorubicin—stomach cancer	0.000167	0.000399	CcSEcCtD
Entacapone—Dyspnoea—Epirubicin—stomach cancer	0.000166	0.000397	CcSEcCtD
Entacapone—Somnolence—Epirubicin—stomach cancer	0.000166	0.000396	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000166	0.00325	CbGpPWpGaD
Entacapone—Anorexia—Doxorubicin—stomach cancer	0.000165	0.000393	CcSEcCtD
Entacapone—Nausea—Docetaxel—stomach cancer	0.000164	0.000392	CcSEcCtD
Entacapone—Feeling abnormal—Methotrexate—stomach cancer	0.000164	0.000392	CcSEcCtD
Entacapone—Dyspepsia—Epirubicin—stomach cancer	0.000164	0.000392	CcSEcCtD
Entacapone—Gastrointestinal pain—Methotrexate—stomach cancer	0.000163	0.000389	CcSEcCtD
Entacapone—COMT—Metabolism—PLIN2—stomach cancer	0.000162	0.00319	CbGpPWpGaD
Entacapone—Decreased appetite—Epirubicin—stomach cancer	0.000162	0.000387	CcSEcCtD
Entacapone—Hypotension—Doxorubicin—stomach cancer	0.000161	0.000385	CcSEcCtD
Entacapone—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000161	0.000385	CcSEcCtD
Entacapone—Fatigue—Epirubicin—stomach cancer	0.000161	0.000384	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GMPR2—stomach cancer	0.000161	0.00315	CbGpPWpGaD
Entacapone—Pain—Epirubicin—stomach cancer	0.00016	0.000381	CcSEcCtD
Entacapone—Constipation—Epirubicin—stomach cancer	0.00016	0.000381	CcSEcCtD
Entacapone—Nausea—Capecitabine—stomach cancer	0.000159	0.00038	CcSEcCtD
Entacapone—Urticaria—Methotrexate—stomach cancer	0.000158	0.000378	CcSEcCtD
Entacapone—COMT—Metabolism—CA2—stomach cancer	0.000158	0.0031	CbGpPWpGaD
Entacapone—Body temperature increased—Methotrexate—stomach cancer	0.000158	0.000376	CcSEcCtD
Entacapone—Abdominal pain—Methotrexate—stomach cancer	0.000158	0.000376	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000157	0.000376	CcSEcCtD
Entacapone—Insomnia—Doxorubicin—stomach cancer	0.000156	0.000373	CcSEcCtD
Entacapone—Paraesthesia—Doxorubicin—stomach cancer	0.000155	0.00037	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000155	0.00304	CbGpPWpGaD
Entacapone—Dyspnoea—Doxorubicin—stomach cancer	0.000154	0.000368	CcSEcCtD
Entacapone—COMT—Metabolism—PGAM1—stomach cancer	0.000154	0.00302	CbGpPWpGaD
Entacapone—COMT—Metabolism—NT5E—stomach cancer	0.000154	0.00302	CbGpPWpGaD
Entacapone—Feeling abnormal—Epirubicin—stomach cancer	0.000154	0.000367	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—stomach cancer	0.000153	0.000367	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000153	0.003	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Epirubicin—stomach cancer	0.000153	0.000364	CcSEcCtD
Entacapone—Dyspepsia—Doxorubicin—stomach cancer	0.000152	0.000363	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—stomach cancer	0.000151	0.00296	CbGpPWpGaD
Entacapone—Decreased appetite—Doxorubicin—stomach cancer	0.00015	0.000358	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000149	0.000356	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—stomach cancer	0.000149	0.000355	CcSEcCtD
Entacapone—Urticaria—Epirubicin—stomach cancer	0.000148	0.000354	CcSEcCtD
Entacapone—Pain—Doxorubicin—stomach cancer	0.000148	0.000353	CcSEcCtD
Entacapone—Constipation—Doxorubicin—stomach cancer	0.000148	0.000353	CcSEcCtD
Entacapone—Abdominal pain—Epirubicin—stomach cancer	0.000147	0.000352	CcSEcCtD
Entacapone—Body temperature increased—Epirubicin—stomach cancer	0.000147	0.000352	CcSEcCtD
Entacapone—Hypersensitivity—Methotrexate—stomach cancer	0.000147	0.000351	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SUCLG1—stomach cancer	0.000147	0.00288	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—IDH3B—stomach cancer	0.000147	0.00288	CbGpPWpGaD
Entacapone—COMT—Metabolism—PLCE1—stomach cancer	0.000147	0.00288	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALDH7A1—stomach cancer	0.000147	0.00288	CbGpPWpGaD
Entacapone—Asthenia—Methotrexate—stomach cancer	0.000143	0.000342	CcSEcCtD
Entacapone—Feeling abnormal—Doxorubicin—stomach cancer	0.000142	0.00034	CcSEcCtD
Entacapone—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000141	0.000337	CcSEcCtD
Entacapone—Pruritus—Methotrexate—stomach cancer	0.000141	0.000337	CcSEcCtD
Entacapone—COMT—Metabolism—UMPS—stomach cancer	0.000141	0.00276	CbGpPWpGaD
Entacapone—Hypersensitivity—Epirubicin—stomach cancer	0.000137	0.000328	CcSEcCtD
Entacapone—Urticaria—Doxorubicin—stomach cancer	0.000137	0.000328	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NDUFV1—stomach cancer	0.000136	0.00268	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NDUFS1—stomach cancer	0.000136	0.00268	CbGpPWpGaD
Entacapone—Abdominal pain—Doxorubicin—stomach cancer	0.000136	0.000326	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—stomach cancer	0.000136	0.000326	CcSEcCtD
Entacapone—Diarrhoea—Methotrexate—stomach cancer	0.000136	0.000326	CcSEcCtD
Entacapone—Asthenia—Epirubicin—stomach cancer	0.000134	0.00032	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000133	0.00262	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—stomach cancer	0.000133	0.00261	CbGpPWpGaD
Entacapone—Pruritus—Epirubicin—stomach cancer	0.000132	0.000315	CcSEcCtD
Entacapone—Dizziness—Methotrexate—stomach cancer	0.000132	0.000315	CcSEcCtD
Entacapone—COMT—Metabolism—PDHA1—stomach cancer	0.000131	0.00257	CbGpPWpGaD
Entacapone—COMT—Metabolism—ECHS1—stomach cancer	0.000131	0.00257	CbGpPWpGaD
Entacapone—Diarrhoea—Epirubicin—stomach cancer	0.000128	0.000305	CcSEcCtD
Entacapone—Hypersensitivity—Doxorubicin—stomach cancer	0.000127	0.000304	CcSEcCtD
Entacapone—Vomiting—Methotrexate—stomach cancer	0.000127	0.000303	CcSEcCtD
Entacapone—Rash—Methotrexate—stomach cancer	0.000126	0.0003	CcSEcCtD
Entacapone—Dermatitis—Methotrexate—stomach cancer	0.000126	0.0003	CcSEcCtD
Entacapone—Headache—Methotrexate—stomach cancer	0.000125	0.000298	CcSEcCtD
Entacapone—Asthenia—Doxorubicin—stomach cancer	0.000124	0.000296	CcSEcCtD
Entacapone—Dizziness—Epirubicin—stomach cancer	0.000123	0.000295	CcSEcCtD
Entacapone—COMT—Metabolism—FADS1—stomach cancer	0.000123	0.00241	CbGpPWpGaD
Entacapone—COMT—Metabolism—TYMP—stomach cancer	0.000123	0.00241	CbGpPWpGaD
Entacapone—Pruritus—Doxorubicin—stomach cancer	0.000122	0.000292	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PGLS—stomach cancer	0.000122	0.00239	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BLVRB—stomach cancer	0.000122	0.00239	CbGpPWpGaD
Entacapone—Vomiting—Epirubicin—stomach cancer	0.000119	0.000283	CcSEcCtD
Entacapone—Nausea—Methotrexate—stomach cancer	0.000118	0.000283	CcSEcCtD
Entacapone—Diarrhoea—Doxorubicin—stomach cancer	0.000118	0.000282	CcSEcCtD
Entacapone—Rash—Epirubicin—stomach cancer	0.000118	0.000281	CcSEcCtD
Entacapone—Dermatitis—Epirubicin—stomach cancer	0.000118	0.000281	CcSEcCtD
Entacapone—Headache—Epirubicin—stomach cancer	0.000117	0.000279	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PPAP2A—stomach cancer	0.000116	0.00228	CbGpPWpGaD
Entacapone—COMT—Metabolism—SREBF2—stomach cancer	0.000115	0.00226	CbGpPWpGaD
Entacapone—Dizziness—Doxorubicin—stomach cancer	0.000114	0.000273	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000114	0.00223	CbGpPWpGaD
Entacapone—COMT—Metabolism—RORA—stomach cancer	0.000114	0.00223	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000112	0.00219	CbGpPWpGaD
Entacapone—Nausea—Epirubicin—stomach cancer	0.000111	0.000265	CcSEcCtD
Entacapone—Vomiting—Doxorubicin—stomach cancer	0.00011	0.000262	CcSEcCtD
Entacapone—Rash—Doxorubicin—stomach cancer	0.000109	0.00026	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—stomach cancer	0.000109	0.00026	CcSEcCtD
Entacapone—Headache—Doxorubicin—stomach cancer	0.000108	0.000258	CcSEcCtD
Entacapone—COMT—Metabolism—ALDOB—stomach cancer	0.000107	0.00209	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—FBP1—stomach cancer	0.000103	0.00203	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NDUFA2—stomach cancer	0.000103	0.00203	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CA1—stomach cancer	0.000103	0.00203	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CKB—stomach cancer	0.000103	0.00203	CbGpPWpGaD
Entacapone—Nausea—Doxorubicin—stomach cancer	0.000103	0.000245	CcSEcCtD
Entacapone—COMT—Metabolism—ALOX5—stomach cancer	9.92e-05	0.00195	CbGpPWpGaD
Entacapone—COMT—Metabolism—DPYD—stomach cancer	9.76e-05	0.00191	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLIN2—stomach cancer	9.73e-05	0.00191	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CA2—stomach cancer	9.46e-05	0.00186	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NT5E—stomach cancer	9.22e-05	0.00181	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PGAM1—stomach cancer	9.22e-05	0.00181	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—HRAS—stomach cancer	9.14e-05	0.00179	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALDH7A1—stomach cancer	8.8e-05	0.00173	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLCE1—stomach cancer	8.8e-05	0.00173	CbGpPWpGaD
Entacapone—COMT—Neuronal System—MAPK1—stomach cancer	8.72e-05	0.00171	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTT1—stomach cancer	8.63e-05	0.00169	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP2A6—stomach cancer	8.53e-05	0.00167	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UMPS—stomach cancer	8.43e-05	0.00165	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKR1C3—stomach cancer	8.3e-05	0.00163	CbGpPWpGaD
Entacapone—COMT—Metabolism—ENO1—stomach cancer	8.08e-05	0.00159	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PDHA1—stomach cancer	7.84e-05	0.00154	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ECHS1—stomach cancer	7.84e-05	0.00154	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—FADS1—stomach cancer	7.37e-05	0.00145	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TYMP—stomach cancer	7.37e-05	0.00145	CbGpPWpGaD
Entacapone—COMT—Metabolism—CD44—stomach cancer	7.17e-05	0.00141	CbGpPWpGaD
Entacapone—COMT—Neuronal System—HRAS—stomach cancer	7e-05	0.00137	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SREBF2—stomach cancer	6.9e-05	0.00135	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—RORA—stomach cancer	6.82e-05	0.00134	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALDOB—stomach cancer	6.39e-05	0.00125	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPP2R1A—stomach cancer	6.1e-05	0.0012	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.03e-05	0.00118	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.01e-05	0.00118	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTP1—stomach cancer	5.98e-05	0.00117	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALOX5—stomach cancer	5.94e-05	0.00117	CbGpPWpGaD
Entacapone—COMT—Metabolism—HMOX1—stomach cancer	5.9e-05	0.00116	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—DPYD—stomach cancer	5.85e-05	0.00115	CbGpPWpGaD
Entacapone—COMT—Metabolism—TYMS—stomach cancer	5.56e-05	0.00109	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTM1—stomach cancer	5.5e-05	0.00108	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.3e-05	0.00104	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTT1—stomach cancer	5.17e-05	0.00101	CbGpPWpGaD
Entacapone—COMT—Metabolism—ERCC2—stomach cancer	5.17e-05	0.00101	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2A6—stomach cancer	5.11e-05	0.001	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKR1C3—stomach cancer	4.97e-05	0.000975	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTHFR—stomach cancer	4.86e-05	0.000953	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ENO1—stomach cancer	4.84e-05	0.00095	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.76e-05	0.000935	CbGpPWpGaD
Entacapone—COMT—Metabolism—CAV1—stomach cancer	4.48e-05	0.000879	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOA1—stomach cancer	4.47e-05	0.000877	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CD44—stomach cancer	4.3e-05	0.000843	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.17e-05	0.000818	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARG—stomach cancer	3.94e-05	0.000773	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPP2R1A—stomach cancer	3.65e-05	0.000717	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTP1—stomach cancer	3.58e-05	0.000703	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALB—stomach cancer	3.54e-05	0.000695	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMOX1—stomach cancer	3.53e-05	0.000693	CbGpPWpGaD
Entacapone—COMT—Metabolism—NOS3—stomach cancer	3.39e-05	0.000665	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TYMS—stomach cancer	3.33e-05	0.000654	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM1—stomach cancer	3.29e-05	0.000646	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—stomach cancer	3.1e-05	0.000608	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ERCC2—stomach cancer	3.1e-05	0.000607	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTHFR—stomach cancer	2.91e-05	0.000571	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAV1—stomach cancer	2.68e-05	0.000527	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOA1—stomach cancer	2.68e-05	0.000525	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.56e-05	0.000503	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARG—stomach cancer	2.36e-05	0.000463	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALB—stomach cancer	2.12e-05	0.000416	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NOS3—stomach cancer	2.03e-05	0.000398	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CA—stomach cancer	1.91e-05	0.000374	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—stomach cancer	1.86e-05	0.000364	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CA—stomach cancer	1.14e-05	0.000224	CbGpPWpGaD
